Therefore, more sophisticated models containing not only inhibitory molecules but also the complex involvement of multiple kinases are required for further clarification of the regulatory mechanisms underlying the increase in the phosphorylation rate on a network-wide scale.
However, in contrast to this past study, which found an overrepresentation of genes required for normal protein homeostasis, mitochondrial network structure and sarcomere structure, we found that the distribution of kinases required to maintain multiple processes within muscle was not significantly different from a normal distribution (χ, GraphPad Prism).
Addressing these two experimental issues, by optimizing conditions, testing more compounds, and monitoring effects on multiple kinases, would require substantial efforts and unnecessarily further delay the publication of our central findings regarding mutual exclusivity and synthetic lethality.
For each of the processes studied there appear to be many more specific kinases required than kinases required for multiple processes to be normal within muscle.
In this study, we took a multi-level functional genomics approach to identify kinases required for normal function of individual and multiple processes within a single tissue in vivo.
The elevated concentration of UCN-01 needed to kill most GSCs suggests that simultaneous inhibition of multiple kinases may be required.
Of the 1508 kinases featured in RKD 2.0, functions for all except 61 kinases require further examination.
The phosphorylation of substrate proteins by kinases requires cognate pairs of substrates and kinases.
Likewise, Tie2, an endothelium-specific receptor tyrosine kinase required for blood vessel maturation, contains multiple transcription start sites and encodes five uORFs.
Each are novel small molecule inhibitors of ALK5 kinase (or TGFβ type 1 receptor kinase), required for TGFβ 1 signaling.
